Elevidys 1.33 × 1013 vg/mL suspension for intravenous infusion Images
Generic Name: delandistrogene moxeparvovec
This medication has been identified as Elevidys 1.33 × 1013 vg/mL suspension for intravenous infusion. It is supplied by Sarepta Therapeutics, Inc.
Elevidys is used in the treatment of Duchenne Muscular Dystrophy and belongs to the drug class miscellaneous uncategorized agents. Elevidys 1.33 × 1013 vg/mL suspension for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Elevidys
- Generic Name
- delandistrogene moxeparvovec
- Strength
- 1.33 × 1013 vg/mL suspension for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Miscellaneous uncategorized agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sarepta Therapeutics, Inc.
- National Drug Code (NDC)
More about Elevidys (delandistrogene moxeparvovec)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
Patient resources
- Elevidys drug information
- Elevidys (10.5-11.4 kg)
- Elevidys (11.5-12.4 kg)
- Elevidys (14.5-15.4 kg)
- Elevidys (17.5-18.4 kg)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
